A 500mg dose of metformin can produce modest weight loss, but the results are smaller than most people expect. In the largest long-term trial tracking this, participants taking metformin lost an average of about 2% of their body weight, which works out to roughly 4 pounds for someone weighing 200 pounds. That’s real, measurable change, but it’s not dramatic. And 500mg is the starting dose, not the dose most commonly linked to those outcomes.
What 500mg Actually Does in Your Body
Metformin was designed to lower blood sugar, but it triggers a chain of events that also reduces appetite. When metformin stimulates glucose breakdown, it generates lactate as a byproduct. That lactate combines with an amino acid to form a molecule called lac-phe, the same “anti-hunger” molecule your body produces after a hard sprint workout. Researchers at Stanford Medicine confirmed that lac-phe is made by cells lining the intestine, and it signals the brain to dial down hunger. When scientists blocked this molecule in mice, the appetite suppression and weight loss disappeared entirely.
Metformin also shifts the balance of bacteria in your upper small intestine, increasing beneficial species like Lactobacillus. This change improves how your gut senses glucose and may boost your body’s natural production of GLP-1, the same hormone that newer weight loss drugs like semaglutide target directly. So metformin nudges several of the same biological levers as intense exercise and injectable weight loss medications, just more gently.
How Much Weight Loss to Realistically Expect
The Diabetes Prevention Program, one of the largest and longest trials ever conducted on metformin, followed participants for over 10 years. Those taking metformin lost an average of 2% of their body weight compared to essentially zero change in the placebo group. The people who stuck with it consistently did better: highly adherent users lost 3.5% of their starting weight, averaging about 7 pounds. That weight loss held steady for the full decade of follow-up, which is notable since many interventions show weight creeping back after a year or two.
Most of these participants were taking higher doses than 500mg. The typical therapeutic range for weight-related effects runs from 1,000mg to 2,000mg daily. A 500mg dose is generally where doctors start to let your body adjust, then increase over several weeks. Staying at 500mg long-term will likely produce results on the lower end of that 2 to 3.5% range, if any measurable change occurs at all.
When Results Typically Appear
Weight loss from metformin generally starts becoming visible after about 4 weeks and accumulates mostly during the first 6 to 12 months. This isn’t a medication that produces a noticeable drop in the first week. The timeline is gradual, driven primarily by reduced appetite rather than any dramatic metabolic shift. If you’re weighing yourself daily, you probably won’t notice the effect above normal daily fluctuations for at least a month.
How It Compares to GLP-1 Medications
The newer injectable weight loss drugs work on some of the same pathways but produce considerably larger effects. In a 16-week comparison study, participants on semaglutide lost an average of 4.5 kg (about 10 pounds) while those on metformin lost 2.9 kg (about 6.4 pounds). Semaglutide also reduced waist circumference by roughly twice as much. Metformin produces real but modest changes; GLP-1 medications are in a different category of effectiveness. The tradeoff is cost and accessibility. Metformin is generic, inexpensive, and widely prescribed, while GLP-1 drugs can cost over $1,000 per month without insurance coverage.
Side Effects at the Starting Dose
Up to 25% of people taking metformin experience gastrointestinal side effects, primarily nausea, diarrhea, and stomach cramping. About 5% find the medication intolerable and have to stop. These effects are most common when starting the drug or increasing the dose, which is exactly why 500mg is the entry point. Taking it with food and using the extended-release formulation both help reduce gut symptoms. Some of the digestive disruption comes from metformin increasing bile salt concentrations in the intestine, which draws water into the gut and can cause loose stools.
At 500mg, side effects tend to be milder than at higher doses. Many people tolerate this level well and only run into trouble when the dose climbs toward 1,500 or 2,000mg.
What Happens If You Stop Taking It
Weight regain after stopping metformin is common, especially if you’ve only been on it for a short time. In one study of women with PCOS, those who used metformin for a shorter duration gained significant weight within 6 months of stopping, going from a median of 92 kg to 96 kg. Longer-term users also tended to regain weight, but less of it, and a higher percentage (27% versus 15%) managed to keep their weight stable after discontinuation. The pattern suggests metformin works best as an ongoing treatment rather than a short course, and that the longer you take it, the more likely some of the behavioral and metabolic changes persist.
The Practical Bottom Line on 500mg
A 500mg dose of metformin is a starting dose, not a weight loss dose. It will begin activating the hunger-reducing pathways in your gut, but the clinical evidence for meaningful weight loss comes from doses of 1,000 to 2,000mg daily, taken consistently over months to years. If your doctor has prescribed 500mg as a first step with plans to increase, that’s a standard approach. If you’re hoping 500mg alone will produce significant results, the evidence suggests you’ll likely see little to no change on the scale at that dose.
Metformin works best as one piece of a larger approach. Its appetite-reducing effects can make it easier to eat less, but it won’t overcome a caloric surplus on its own. People in clinical trials who lost the most weight were also the most adherent to taking the medication consistently, suggesting that the modest daily appetite suppression compounds over time into measurable results only when the drug is taken reliably and paired with some degree of dietary awareness.